Abu Dhabi’s Mubadala invests £350m in UK-headquartered IVC Evidensia

Abu Dhabi’s Mubadala Investment Company announced on Sunday that it has invested £350m in IVC Evidensia, Europe’s largest veterinary care provider.

Headquartered in Bristol, UK, IVC Evidensia operates a network of more than 1,500 veterinary clinics and hospitals in 12 countries across Europe, providing services for over four million pets.

Founded in 2011, the company operates a decentralised model, supported by a range of integrated services such as procurement, veterinary advisers and clinical boards.

IVC Evidensia is widely recognised for pioneering new standards both for clinical excellence and staff wellbeing within its sector.

IVC was originally acquired by EQT Private Equity in December 2016, and subsequently merged with Evidensia, the Swedish veterinary group, in May 2017.

Since then, the company has further strengthened its position as Europe’s leading veterinary services provider through organic growth and strategic add-on acquisitions.

“Our investment in IVC Evidensia aligns well with our focus on investing in market leading consumer businesses in resilient and growing sectors. We are excited to be partnering with EQT, Silver Lake, Nestlé and IVC’s world-class management team to help drive the company’s continued leadership and innovation in pet care,” said Justin Sabet-Peyman, head of consumer at Mubadala.

Earlier this year Mubadala announced a announced a joint £1bn investment in the UK life sciences sector along with the UK Government.

Read: Abu Dhabi’s Mubadala to invest £800m in UK life sciences sector

Mubadala will invest £800m, while the UK will pitch in £200m, part of the UAE-UK Sovereign Investment Partnership (SIP). Over five years, the SIP will invest across several tech and innovation-led sectors such as energy transition and infrastructure.